VF
CTSO icon

Virtu Financial’s Cytosorbents Corp CTSO Stock Holding History

Virtu Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,780
Closed -$7K – 1743
2025
Q4 		$7K Buy
+10,780
New +$8.29K ﹤0.01% 1532
2024
Q1 		– Sell
-20,215
Closed -$22K – 1524
2023
Q4 		$22K Buy
+20,215
New +$30K ﹤0.01% 1307
2022
Q1 		– Sell
-10,898
Closed -$46K – 1595
2021
Q4 		$46K Buy
+10,898
New +$61.1K ﹤0.01% 1363
2019
Q1 		– Sell
-11,379
Closed -$92K – 1472
2018
Q4 		$92K Buy
+11,379
New +$113K 0.01% 1152
2018
Q2 		– Sell
-13,733
Closed -$97K – 2051
2018
Q1 		$97K Buy
+13,733
New +$104K 0.01% 1583
2017
Q4 		– Sell
-54,358
Closed -$337K – 2439
2017
Q3 		$337K Buy
+54,358
New +$277K 0.02% 1275

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Virtu Financial's CTSO Position: Q1 2026 in Review

Virtu Financial sold out of Cytosorbents Corp (CTSO) in Q1 2026, closing a stake of 10,780 shares — an estimated $7K sold.

Virtu Financial first reported a position in CTSO in Q3 2017 and held it in 6 quarters. The position peaked at $337K in Q3 2017. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Virtu Financial reported no remaining Cytosorbents Corp position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,780 Cytosorbents Corp shares in Q1 2026, an estimated $7K.
  • Virtu Financial first reported a position in Cytosorbents Corp in Q3 2017 and held it in 6 quarters.
  • Virtu Financial's Cytosorbents Corp position peaked at $337K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.